Patient receives diagnosis for CAD|Loyola Medicine

Former pro baseball player receives vital diagnosis from new noninvasive coronary artery test

Loyola is the first hospital in Illinois to offer HeartFlow® fractional flow reserve-computed tomography (FFRCT), a new, noninvasive technology to test for heart disease. HeartFlow® employs noninvasive CT scans to calculate how much blood is flowing through diseased coronary arteries that have narrowed due to  plaque. As a result, the patient does not need an invasive angiogram that involves threading a catheter to the heart. HeartFlow® can benefit patients who have experienced symptoms such as chest pain and shortness of breath, but have not been diagnosed with heart disease. For more information, please visit or call 888-584-7888.